Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Sep 23, 2026
Securitize (SECZ) Climbs +112% on Tokenization Regulatory Shift

Securitize (SECZ) Climbs +112% on Tokenization Regulatory Shift

Key Takeaways

  • SECZ has surged roughly 112% over the past 30 days, climbing from a close of $6.13 on August 21 to $13.00 on September 22.
  • The primary catalyst was the SEC's "Innovation Exemption," which cleared a path for limited trading of tokenized U.S. stocks on approved platforms.
  • A wave of bullish analyst coverage followed, including Cantor Fitzgerald (Overweight, $21.20 target) and Rosenblatt ($13 target).
  • The rally has been volatile: earlier in the quarter the stock dropped sharply after weaker-than-expected second-quarter results.
  • Securitize remains pre-profit, reporting a 5% year-over-year revenue decline to $14.4 million and a widened net loss in Q2 2026.

Securitize's Role in Tokenized Real-World Assets

Securitize Corp. operates one of the leading platforms for tokenizing real-world assets. It allows issuers, asset managers, and financial institutions to issue, manage, and trade digital securities on blockchain while staying compliant with regulations. Its services include digital securities issuance, SEC-registered transfer agency, broker-dealer support, fund administration, and an SEC-regulated Alternative Trading System (ATS).

The firm oversees more than $4 billion in tokenized assets and works with major partners such as BlackRock (BLK), Apollo (APO), KKR (KKR), Hamilton Lane (HLNE), and VanEck. It provides the infrastructure for BlackRock's tokenized money-market fund, BUIDL. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

SECZ Stock Performance Over the Past 30 Days and Quarter

Over the last 30 days, SECZ posted a strong advance, gaining approximately 112% from $6.13 on August 21 to $13.00 on September 22. Momentum picked up after the mid-September regulatory announcement, with the stock closing at $8.93 on September 17, then $10.86 on September 18, before hitting an intraday high of $13.93 on September 21 and settling at $13.00 on September 22.

The quarterly view shows more volatility. SECZ began trading on the NYSE on July 2, 2026, closing at $12.30 that day. It declined through July and August, reaching a low near $5.39 on August 17 following soft second-quarter results, before the sharp rebound. From the July 2 debut close to $13.00 on September 22, the stock is up about 5.7% overall.

Key Driver of the Recent 30-Day Rally

The main force behind the move was regulatory. On September 17, the SEC issued temporary, conditional exemptive relief known as the "Innovation Exemption," permitting approved platforms to issue and trade tokenized versions of publicly traded U.S. stocks. Given Securitize's regulated tokenization capabilities across issuance, custody, transfer agency, and trading, investors saw it as a direct beneficiary. I also checked this using Tickeron’s AI Trend Prediction Engine to confirm the momentum signals.

Analyst notes added fuel. Cantor Fitzgerald started coverage with an Overweight rating and $21.20 target, noting that tokenization could reshape financial infrastructure on a historic scale. Rosenblatt lifted its target to $13 from $11 while keeping a Buy rating, and Needham initiated with a Buy in early September. Positive media coverage on the broader tokenization opportunity supported sector momentum.

Quarterly Context and Earnings Impact

The quarterly story centers on the transition to a public company and mixed financial results. The business combination with Cantor Equity Partners II closed, and trading began on the NYSE on July 2, 2026, in a deal expected to raise roughly $400 million in gross proceeds.

Sentiment turned in mid-August after second-quarter figures. Revenue came in at $14.4 million, down 5% year-over-year, while the net loss widened 253% to $21.69 million amid platform investments. Average tokenized assets under management rose 16% year-over-year, with about $1 billion added during the quarter. The softer bottom line led to a selloff, but the September regulatory update shifted focus back to longer-term growth prospects.

Forward Drivers for SECZ Investors

Those following SECZ will want to track implementation of the Innovation Exemption, including which platforms gain approval and how quickly tokenized stock trading develops. Additional partnership announcements, growth in tokenized assets under management, and progress toward turning that base into revenue will matter. The next earnings report will be watched for any reversal in the top-line trend and narrowing losses, consistent with management's aim for positive adjusted EBITDA. Broader macro conditions, digital-asset sentiment, and further regulatory developments could also shape the path ahead.

Integrating Tickeron AI Tools Into My Process

I often turn to Tickeron’s AI Daily Buy/Sell Signals when evaluating momentum names like this one. The platform helps surface timely signals across thousands of tickers and lets me cross-check patterns against my own analysis without replacing independent judgment. It has become a useful part of staying on top of fast-moving sectors such as tokenization.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SECZ

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


Momentum Indicator for SECZ turns positive, indicating new upward trend

SECZ saw its Momentum Indicator move above the 0 level on August 27, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 16 similar instances where the indicator turned positive. In 14 of the 16 cases, the stock moved higher in the following days. The odds of a move higher are at 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SECZ just turned positive on August 20, 2026. Looking at past instances where SECZ's MACD turned positive, the stock continued to rise in 7 of 10 cases over the following month. The odds of a continued upward trend are 70%.

SECZ moved above its 50-day moving average on September 08, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SECZ crossed bullishly above the 50-day moving average on September 11, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 2 of 4 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.

Following a +51.18% 3-day Advance, the price is estimated to grow further. Considering data from situations where SECZ advanced for three days, in 46 of 67 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

The Aroon Indicator entered an Uptrend today. In 48 of 58 cases where SECZ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 83%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SECZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.

SECZ broke above its upper Bollinger Band on September 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. SECZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (51.950). P/E Ratio (0.000) is within average values for comparable stocks, (82.426). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.152). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (19.011) is also within normal values, averaging (70.180).

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SECZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

Notable companies

The most notable companies in this group are Salesforce (NYSE:CRM), Shopify Inc (NASDAQ:SHOP), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Adobe (NASDAQ:ADBE), Datadog (NASDAQ:DDOG), Intuit (NASDAQ:INTU), Atlassian Corp (NASDAQ:TEAM), Workday (NASDAQ:WDAY), Autodesk (NASDAQ:ADSK).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 10.03B. The market cap for tickers in the group ranges from 39 to 242.54B. SAPGF holds the highest valuation in this group at 242.54B. The lowest valued company is STIXF at 39.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was 1%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 8%. BTTC experienced the highest price growth at 109%, while FTFT experienced the biggest fall at -44%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was 27%. For the same stocks of the Industry, the average monthly volume growth was 14% and the average quarterly volume growth was -36%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 76
Price Growth Rating: 59
SMR Rating: 77
Profit Risk Rating: 94
Seasonality Score: -13 (-100 ... +100)
View a ticker or compare two or three
SECZ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry PackagedSoftware

Industry
N/A
Address
78 South West 7th Street
Phone
+1 646 918-5012
Employees
203
Web
https://www.securitize.io
Interact to see
Advertisement
The Fed kept rates at 3.5–3.75% and signaled a “higher for longer” stance, with no urgency to cut and a willingness to tighten again if inflation stalls. This backdrop tends to favor quality growth, financials, energy, industrials, and health care, while pressuring long‑duration, leveraged sectors like speculative tech, small caps, utilities, and REITs.
PICS shares fell over 20% today, reversing much of their post‑IPO bounce and dropping well below the US$19 IPO price after initially trading in the mid‑US$15–16 range. The selloff followed PicPay’s Q4 and full‑year 2025 results, which showed strong revenue growth but highlighted thin margins, intense competition and ongoing execution risk in credit underwriting and payments.
RCAT shares fell over 16% today, dropping from recent levels near US$17 toward the mid‑US$14–15 range, after trading as high as US$18.78 in the past year and more than tripling from a 52‑week low of US$4.60.
HYMC shares fell over 13% today, sliding from the mid‑US$30s toward roughly US$31, after trading between US$2.30 and US$58.73 over the past 12 months and closing near US$39 just a few sessions ago.
USAS fell over 10% today, trading around US$5.83 by early afternoon from a previous close of US$6.55 — a one‑day decline of roughly 11% — as more than 5.9 million shares changed hands. The stock had surged earlier in 2026, with some data showing a move from about US$1.11 in March 2025 to over US$7.30 in mid‑March 2026 — a gain of more than 500% — leaving it vulnerable to profit‑taking.
CENX fell about 8.9% today, dropping US$4.94 to US$50.40 by midday, after closing at US$55.34 yesterday; shares now sit roughly 15% below their 52‑week high of US$59.12 but remain far above the 12‑month low of US$13.05. Q4 2025 results showed net sales of US$633.7 million and adjusted net income of US$128.2 million (US$1.25 per share), with adjusted EBITDA of US$170.6 million — a big sequential improvement — but GAAP net income was just US$1.8 million (US$0.02 per share), underscoring earnings volatility.
CNL shares fell over 8% today, trading down from around C$22.90 toward the low‑C$21s, after recently setting a new 1‑year high at C$28.99 on March 2 and gaining more than 70% over the past 12 months.
SMCI shares are plunging approximately 26% in Friday premarket trading, extending sharp after-hours losses from Thursday's session close of $30.79. The primary catalyst is a federal indictment unsealed March 19, 2026, charging three individuals associated with Super Micro — including a company co-founder — with conspiring to illegally export billions of dollars in AI server technology to China.
PL shares are surging approximately 19% in premarket trading on March 20, 2026, building on an 8.67% gain during the regular session on March 19. The primary catalyst is a blowout Q4 fiscal year 2026 earnings report released after the close on March 19, with quarterly revenue of $86.8 million — an 11.55% beat against consensus expectations of $77.81 million.
Unusual Machines (UMAC) is trading down approximately -8.60% in premarket on March 20, 2026, extending losses from the prior session. The primary catalyst is a proposed public stock offering announced after the market close on March 19, 2026, raising dilution concerns among investors.
FDX surged approximately 7% in premarket trading on March 20, 2026, moving from the prior session close of $356.11 to around $381. The primary catalyst is a blowout fiscal Q3 2026 earnings report, with adjusted EPS of $5.25 — beating Wall Street's consensus estimate of $4.13 by more than 27%.
Kingsoft Cloud Holdings Limited (KC) shares plunged about 9% in the most recent session, extending a sharp pullback after a recent rally. The selloff reflects mounting concerns around profitability, with the company still loss-making and showing weak multi-year revenue growth.
BAK shares fell roughly 11% in the latest trading session, marking a sharp single-day drop for the Brazilian petrochemical producer The decline comes amid persistent concerns about high leverage, a weaker credit profile, and soft petrochemical margins in a challenging macro environment for chemicals​
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.